Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

Dean Fennell

Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

Dean Fennell

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	556-561
Number of pages	6
Journal	Gut
Volume	51
Issue number	4
Publication status	Published - Oct 2002

ASJC Scopus subject areas

Gastroenterology

Cite this

@article{e60f6724d41a4c9b81555c206b039082,

title = "Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.",

author = "Dean Fennell",

year = "2002",

month = oct,

language = "English",

volume = "51",

pages = "556--561",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

AU - Fennell, Dean

PY - 2002/10

Y1 - 2002/10

UR - https://www.scopus.com/pages/publications/0036786173

M3 - Article

C2 - 9745726

SN - 0017-5749

VL - 51

SP - 556

EP - 561

JO - Gut

JF - Gut

IS - 4

ER -

Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

ASJC Scopus subject areas

Other files and links

Cite this